From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

MGC Pharmaceuticals – another cup of death spiral vicar?

By Tom Winnifrith | Wednesday 22 February 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The word on the Street is that the level of boardroom greed at MGC Pharmaceuticals (MXC) is causing increasing unrest among some of those hitherto supportive of the company. Meanwhile the share price continues to tank and I think that we can all guess why. The shares were 2.25p, valuing this crock at £70 million, on January 11 2022 when I published this extensive bear dossier HERE. Today they are just 0.475p, off another 15% today and valued at just £13.7 million.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Time left: 00:39:39